Mainstream treatment options for hypoactive sexual desire disorder

Mainstream treatment options for hypoactive sexual desire disorder

Also known as inhibited sexual desire, hypoactive sexual desire disorder is a sexual dysfunction. The main characteristic of this condition is the reduction, absence, or lack of desire for sexual activity, and it is diagnosed by a clinician. This condition will be decided to be a disorder if there are clear difficulties in interpersonal relations and marked distress arising not from another mental condition, drug, or any other disease/disorder. Some of the mainstream treatment options for hypoactive sexual desire disorder are as follows:

  • Counseling: Similar to most other cases of sexual dysfunction, even this condition is treated through counseling in the context of a relationship. It is not necessary that one needs to be in a relationship to either be diagnosed with HSDD or be treated for it. However, the most common factor which has been observed to cause reduced desire and increased distress in women is associated with their relationship status. It is quite common for a couple to participate in sex counseling and therapy. When this counseling starts, the first aim of the clinician would be to identify a biological or a psychological cause for the diagnosed HSDD. If the cause is psychological, the clinician can suggest therapy to the individual or the couple.
    In some cases, problems arise because people hold unrealistic expectations of what or how sexuality is and how the entire process is approached. In this case, education regarding what basic sexuality construes and how to set normal expectations can be helpful. In many cases, stress is the root cause of HSDD as anxiety and low self-esteem results in one not wanting to be intimate with their partner. If this is the case, couples and individuals can work steadily towards identifying the trigger and managing it.
    Without therapy, the focus can be placed on increasing verbal and non-verbal communication, increasing non-sexual intimacy, resolving relationship issues, and sexuality education amongst other options.
    In the case of resolving this condition in men, therapy would depend upon the subtype of HSDD. If the kind of HSDD experienced is either generalized or lifelong, increasing the amount of sexual desire is slightly unlikely. In this case, the focus would be on helping the couple to adapt to the current situation.
    If the type of HSDD is acquired/ situational, psychotherapy can be suggested, either just for the man or both him and his partner. On the other hand, if it is acquired/ generalized, there is a possibility that the condition is biological and the clinician may attempt to resolve the situation.
  • Approved medication: The first medicine that has been approved by the FDA for the treatment of HSDD is Flibanserin. This medicine is used for the treatment of the condition in premenopausal women. One other medicine that has been approved for the treatment of this condition in the USA is bremelanotide, which is also prescribed to premenopausal women.

When there could be multiple reasons at the base of a condition, one would require patience and perseverance to understand the root cause of these conditions. Once the root cause of the condition is found, a course of action can be decided upon.